Evidence-Based Prescription Skincare Reviews
Find the Right Prescription Skincare Treatment
Independent, research-backed reviews of telehealth dermatology platforms — so you can get prescription-strength results without the guesswork.
Browse by Condition
Melasma
Prescription treatments for stubborn dark spots and hyperpigmentation.
Acne
Coming soonCompare prescription retinoids, antibiotics, and custom formulas.
Anti-Aging
Coming soonTretinoin, peptides, and prescription-strength retinoids compared.
Rosacea
Coming soonPrescription options for redness, flushing, and sensitive skin.
Latest Reviews & Guides
Curology Review 2026: Is It Worth It?
We tested Curology's custom formula service for 90 days. Here's what actually happened.
Read Review →Musely Spot Cream: Does It Work for Melasma?
Musely's prescription hydroquinone formula is one of the strongest available online. Our full breakdown.
Read Review →Curology vs Musely: Which Is Better for Dark Spots?
Side-by-side comparison of formulas, pricing, and real patient results for hyperpigmentation.
Read Comparison →Tretinoin for Beginners: What to Expect
Starting tretinoin? Here's the purge timeline, moisturizer pairings, and what dermatologists actually recommend.
Read Guide →Melasma: Causes, Triggers & Best Treatments
Why melasma keeps coming back — and the prescription ingredients with the strongest clinical evidence.
Read Guide →Hers Skincare Review 2026: Is the Prescription Cream Worth It?
Hers prescribes custom tretinoin and azelaic acid formulas for women starting at $25/month. Here's what you get — and the billing gotcha to know before you subscribe.
Read Review →How We Review
Evidence-Based
Every recommendation is grounded in peer-reviewed dermatology research, clinical guidelines, and publicly available ingredient data.
Editorially Independent
Our ratings and recommendations are never influenced by brand relationships or advertising. We follow the same evaluation process for every platform.
No Paid Rankings
Affiliate relationships never influence our ratings. Brands can't pay for better placement.